Exane Derivatives’s ProShares Ultra S&P500 SSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$22.4K Hold
1,000
0.01% 359
2022
Q1
$32.8K Sell
1,000
-4,080
-80% -$131K 0.01% 615
2021
Q4
$186K Hold
5,080
0.05% 352
2021
Q3
$152K Buy
+5,080
New +$161K 0.04% 459
2021
Q1
Sell
-7,000
Closed -$160K 964
2020
Q4
$160K Buy
7,000
+2,080
+42% +$42.7K 0.05% 338
2020
Q3
$90.4K Buy
+4,920
New +$88.5K 0.03% 309

Other funds holding SSO

Exane Derivatives's SSO Position: Q2 2022 in Review

Exane Derivatives held its ProShares Ultra S&P500 (SSO) position steady in Q2 2022 at 1,000 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #359.

Exane Derivatives first reported a position in SSO in Q3 2020 and has held it in 6 quarters since. The position peaked at $186K in Q4 2021. 156 funds tracked by Wall St. Rank hold SSO as of Q2 2022.

  • Exane Derivatives held 1,000 shares of ProShares Ultra S&P500 worth $22.4K as of Q2 2022.
  • Exane Derivatives left its ProShares Ultra S&P500 share count unchanged in Q2 2022.
  • ProShares Ultra S&P500 made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #359 holding.
  • Exane Derivatives first reported a position in ProShares Ultra S&P500 in Q3 2020 and has held it in 6 quarters since.
  • Exane Derivatives's ProShares Ultra S&P500 position peaked at $186K in Q4 2021.
  • 156 funds tracked by Wall St. Rank held ProShares Ultra S&P500 as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.